GCP
IRWD icon

GSA Capital Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

GSA Capital Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
259,512
-394,933
-60% -$1.52M 0.07% 449
2026
Q1 		$2.3M Buy
654,445
+82,832
+14% +$340K 0.14% 118
2025
Q4 		$1.93M Buy
571,613
+262,084
+85% +$681K 0.17% 96
2025
Q3 		$405K Sell
309,529
-411,331
-57% -$426K 0.03% 994
2025
Q2 		$517K Buy
720,860
+196,184
+37% +$154K 0.04% 895
2025
Q1 		$771K Buy
524,676
+510,809
+3,684% +$1.22M 0.07% 507
2024
Q4 		$61K Sell
13,867
-337,326
-96% -$1.37M ﹤0.01% 1527
2024
Q3 		$1.45M Buy
351,193
+232,087
+195% +$1.25M 0.11% 241
2024
Q2 		$777K Sell
119,106
-57,066
-32% -$404K 0.05% 684
2024
Q1 		$1.53M Buy
+176,172
New +$2.14M 0.12% 216
2023
Q3 		– Sell
-63,606
Closed -$677K – 1698
2023
Q2 		$677K Sell
63,606
-39,652
-38% -$426K 0.07% 551
2023
Q1 		$1.09M Buy
103,258
+42,309
+69% +$474K 0.11% 273
2022
Q4 		$755K Buy
60,949
+13,007
+27% +$148K 0.09% 354
2022
Q3 		$497K Buy
47,942
+37,441
+357% +$424K 0.07% 574
2022
Q2 		$121K Sell
10,501
-71,480
-87% -$842K 0.02% 1189
2022
Q1 		$1.03M Buy
+81,981
New +$940K 0.14% 166
2020
Q4 		– Sell
-95,165
Closed -$856K – 1399
2020
Q3 		$856K Buy
+95,165
New +$946K 0.14% 142
2020
Q1 		– Sell
-85,714
Closed -$1.14M – 1296
2019
Q4 		$1.14M Buy
85,714
+1,627
+2% +$17.9K 0.13% 155
2019
Q3 		$722K Buy
+84,087
New +$817K 0.1% 319
2014
Q1 		– Sell
-17,748
Closed -$173K – 1673
2013
Q4 		$173K Buy
+17,748
New +$159K 0.01% 1494
2013
Q3 		– Sell
-18,625
Closed -$155K – 1601
2013
Q2 		$155K Buy
+18,625
New +$226K 0.02% 1156

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GSA Capital Partners's IRWD Position: Q2 2026 in Review

GSA Capital Partners reduced its Ironwood Pharmaceuticals (IRWD) stake by 60% in Q2 2026, selling an estimated $1.52M and leaving 259,512 shares worth $1.09M. The position accounts for 0.07% of the portfolio, ranked #449.

GSA Capital Partners first reported a position in IRWD in Q2 2013 and has held it in 21 quarters since. The position peaked at $2.3M in Q1 2026. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • GSA Capital Partners held 259,512 shares of Ironwood Pharmaceuticals worth $1.09M as of Q2 2026.
  • GSA Capital Partners sold 394,933 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $1.52M.
  • Ironwood Pharmaceuticals made up 0.07% of GSA Capital Partners's portfolio in Q2 2026, its #449 holding.
  • GSA Capital Partners first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 21 quarters since.
  • GSA Capital Partners's Ironwood Pharmaceuticals position peaked at $2.3M in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.